MEDIROM Healthcare Technologies Inc. (MRM)
USD 0.84
(5.87%)
USD 0.84
(5.87%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -631.73 Million | -685.69 Million | -557.23 Million | -366.42 Million | 7.87 Million | 141.87 Million |
| Net Income | 115.4 Million | 148.96 Million | -990.73 Million | -539.17 Million | 17.33 Million | 66.31 Million |
| Depreciation & Amortization | 252.59 Million | 184.05 Million | 126.24 Million | 62.29 Million | 46.17 Million | 44.26 Million |
| Deferred income taxes | -101.63 Million | - | - | - | - | - |
| Stock-based compensation | - | - | 196.85 Million | - | - | 149 Thousand |
| Change in working capital | 498.75 Million | -49.94 Million | 108.5 Million | 267.11 Million | -98.51 Million | -120.39 Million |
| Other non-cash items | -1.49 Billion | -968.77 Million | 1.9 Million | -156.65 Million | 42.87 Million | 151.53 Million |
| Investing Cash Flow | -328.57 Million | 580.43 Million | -83.93 Million | -139.59 Million | -37.93 Million | -79.38 Million |
| Investments in PPE | -135.84 Million | -120.74 Million | -95.65 Million | -73.55 Million | -7.4 Million | -34.29 Million |
| Acquisitions | 584.76 Million | -148 Million | -375.75 Million | -99.19 Million | -3.2 Million | -60.27 Million |
| Investment purchases | -3.09 Million | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -192.73 Million | 849.17 Million | 387.47 Million | 33.15 Million | -27.32 Million | 15.18 Million |
| Financing Cash Flow | 461.2 Million | 340.09 Million | -427.94 Million | 1.43 Billion | 331.99 Million | -74.47 Million |
| Debt repayment | -99.08 Million | 502.34 Million | -251.08 Million | 568.56 Million | -241.91 Million | -254.47 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 560.29 Million | -162.25 Million | -176.86 Million | 863.57 Million | 573.9 Million | 180 Million |
| Accounts receivables | 580.68 Million | -222.38 Million | -37.02 Million | 189.14 Million | -66.87 Million | 30.17 Million |
| Accounts payables | -69.88 Million | - | - | - | - | - |
| Inventory | -25.87 Million | -95.4 Million | -2.44 Million | -2.44 Million | 892 Thousand | 6.92 Million |
| Other working capital | -56.05 Million | 267.84 Million | 147.96 Million | 80.41 Million | -32.53 Million | -157.48 Million |
| Cash at beginning of period | 605.45 Million | 370.61 Million | 1.43 Billion | 513.62 Million | 211.68 Million | 223.67 Million |
| Cash at end of period | 106.34 Million | 605.45 Million | 370.61 Million | 1.43 Billion | 513.62 Million | 211.68 Million |
| Capital Expenditure | -135.84 Million | -120.74 Million | -95.65 Million | -73.55 Million | -7.4 Million | -34.29 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -499.1 Million | 234.83 Million | -1.06 Billion | 926.11 Million | 301.93 Million | -11.99 Million |
| Free Cash Flow | -767.57 Million | -806.43 Million | -652.88 Million | -439.97 Million | 464 Thousand | 107.57 Million |
| Breakdown | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 115.4 Million | 235.23 Million | 235.23 Million | -177.53 Million | -177.53 Million | 148.96 Million |
| Depreciation & Amortization | 252.59 Million | 75.87 Million | 75.87 Million | 50.42 Million | 50.42 Million | 184.05 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 498.75 Million | 262.43 Million | 262.43 Million | -13.05 Million | -13.05 Million | -136.72 Million |
| Other non-cash items | -1.49 Billion | -584.38 Million | -584.38 Million | -164.85 Million | -164.85 Million | -881.99 Million |
| Investing Cash Flow | -328.57 Million | -252.11 Million | -252.11 Million | 87.82 Million | 87.82 Million | 580.43 Million |
| Investments in PPE | -135.84 Million | -39.79 Million | -39.79 Million | -28.12 Million | -28.12 Million | -166.5 Million |
| Acquisitions | - | - | - | - | - | 703.71 Million |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -192.73 Million | -212.31 Million | -212.31 Million | 115.94 Million | 115.94 Million | 43.21 Million |
| Financing Cash Flow | 461.2 Million | 257.27 Million | 257.27 Million | -26.67 Million | -26.67 Million | 340.09 Million |
| Debt repayment | -99.08 Million | - | - | - | - | -207.52 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 560.29 Million | 257.27 Million | 257.27 Million | -26.67 Million | -26.67 Million | 547.61 Million |
| Accounts receivables | 580.68 Million | 333.9 Million | 333.9 Million | -43.56 Million | -43.56 Million | -222.38 Million |
| Accounts payables | - | - | - | - | - | -23.31 Million |
| Inventory | -25.87 Million | 26.92 Million | 26.92 Million | -39.85 Million | -39.85 Million | -95.4 Million |
| Other working capital | -56.05 Million | -98.39 Million | -98.39 Million | 70.37 Million | 70.37 Million | 204.38 Million |
| Cash at beginning of period | 605.45 Million | 113.93 Million | - | 663.06 Million | - | 370.61 Million |
| Cash at end of period | 106.34 Million | 105.51 Million | -5.69 Million | 117.69 Million | -243.86 Million | 605.45 Million |
| Capital Expenditure | -135.84 Million | -39.79 Million | -39.79 Million | -28.12 Million | -28.12 Million | -166.5 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -499.1 Million | -8.41 Million | -5.69 Million | -545.36 Million | -243.86 Million | 234.83 Million |
| Free Cash Flow | -767.57 Million | -50.64 Million | -50.64 Million | -333.13 Million | -333.13 Million | -852.19 Million |
KRG
300199
CING
BAC-PK
FMCCJ
CXDO